The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Technion scientists played a key role in the fight against COVID-19, developing everything from diagnostic testing and protective gear to innovative therapeutics.
In this informative webinar, Technion Professor Moran Bercovici discusses how his microfluidics research could lead to point-of-care testing to detect the coronavirus. Prof. Bercovici and his team have developed methods for direct detection of biomarkers, without requiring time-consuming sample cleanup and amplification. They applied these methods to detect the coronavirus, with the aim of creating a test that could be completed, from sample to answer, in minutes.
For patients already diagnosed with COVID-19, Technion Professor Josué Sznitman and his team were developing an innovative technology that could dramatically improve the efficacy of existing drugs for treating Acute Respiratory Distress Syndrome (ARDS), the leading cause of death in COVID-19 patients. Their Liquid Foam Therapy (LIFT) aims to improve the distribution of surfactants, liquids that coat the surface of the lungs’ air sacs and reduce the energy required for breathing. It’s been shown that COVID-19 depletes the secretion of surfactants, a condition which Prof. Sznitman’s team believes is particularly severe in ARDS.
